ClinicalTrials.gg
Active, not recruitingNCT04913987FLEX-UNIUpdated Sep 24, 2026

Unicompartmental Versus Total Knee Replacement for Medial Compartment Knee Osteoarthritis

An interventional study of Persona Partial Knee (PPK) and Triathlon cruciate-retaining total knee system. in Osteoarthritis, Knee and Arthroplasty, sponsored by Golden Jubilee National Hospital. Active, not recruiting at 1 site in United Kingdom. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-09-24.

Sponsored by Golden Jubilee National Hospital · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 167 studies in Osteoarthritis with a site in United Kingdom — 14 open to participants now, 38 under way, 1 of them phase 3. Osteoarthritis · United Kingdom.

Planned enrollment
89th of 114
40 · median 108
Started
2021
with 4 others
No phase
59 of 167
5 open now
Primary completion
2027-10
later than 18 of 37 live
Registered
134th of 167
by date

Among the 167 studies in Osteoarthritis with a site in United Kingdom, this one is the 89th largest by planned enrollment of the 114 interventional ones that give a count, is one of 5 that started in 2021, is one of 59 with no phase, reaches primary completion later than 18 of the 37 other live ones, and was the 134th registered.

Osteoarthritis

2,978 studies on the registry are indexed under Osteoarthritis; 438 are open to participants now.

Browse Osteoarthritis studies →

Open to participants now

14 of the 167 studies in Osteoarthritis with a site in United Kingdom are open now. Recruiting first, the newest first:

9 more — sign in →

All 14 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 285 Osteoarthritis studies recruiting now, 158 (55%) set no upper age limit and 70 (25%) stop at 75 or younger; 22 take children under 18; 31 take healthy volunteers.

This study: 18 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 167 studies in Osteoarthritis with a site in United Kingdom, or all of them as a file.
02

Study summary

For patients with osteoarthritis affecting only the inner part of the knee, surgeons can offer either a partial knee replacement, which resurfaces the worn compartment alone, or a total knee replacement. Both are recommended treatments, but there is no agreement on when to choose one over the other. Partial knee replacement preserves the anterior cruciate ligament and more of the natural knee, and recovery is usually quicker, but it is used in only about one in ten knee replacements in the United Kingdom.

Studies comparing the two have mostly relied on patient questionnaires, which may not be sensitive enough to detect differences in how the knee actually functions. Studies that have measured movement directly have concentrated on level walking, which is not demanding enough to separate the two operations. Difficulty with stairs is one of the longest lasting problems patients report after knee replacement.

The FLEX-UNI trial will compare the two operations using three-dimensional motion analysis during more demanding everyday activities. Forty patients who are suitable for a partial knee replacement will be randomly allocated to receive either a partial or a total knee replacement. Patients and the researchers measuring their movement will not know which operation was performed. The main measurement is how far the operated knee bends while stepping down from a 20 cm step, measured one year after surgery. Movement during walking, stair climbing, slopes, sitting and standing, and balance will also be measured, along with questionnaires, x-rays, and complications. Results will be compared against measurements from people with healthy knees.

Read the detailed description

FLEX-UNI is a single-centre, prospective, randomized, double-blinded, controlled superiority trial comparing medial unicompartmental knee arthroplasty (UKA) with total knee arthroplasty (TKA) in patients with anteromedial knee osteoarthritis. Forty participants will be randomized 1:1. The trial is conducted at a high-volume elective arthroplasty centre and participants are followed for 12 months.

Participants are identified from the clinic lists of participating consultant orthopaedic surgeons and screened against the eligibility criteria by a member of the research team and by the treating consultant. Following written consent and baseline assessment, participants are randomized using sequentially numbered, opaque, sealed envelopes prepared and opened by a member of the research team not involved in screening, recruitment, or outcome assessment.

Participants allocated to UKA receive a cemented medial fixed-bearing Persona Partial Knee (Zimmer Biomet, Warsaw, Indiana, USA), implanted using a spacer block technique that resurfaces the medial compartment without deliberate correction of limb alignment. Participants allocated to TKA receive a cemented Triathlon cruciate-retaining total knee system without patellar resurfacing (Stryker, Mahwah, New Jersey, USA), implanted using a measured resection technique with a mechanical alignment target. Both procedures use conventional manual instrumentation, without robotic assistance or computer navigation, and are performed by the same group of consultant surgeons, each of whom performs both operations.

Suitability for medial UKA is confirmed intraoperatively at arthrotomy in all participants, including those allocated to TKA. Participants allocated to UKA who are found at arthrotomy to be unsuitable, principally because of disease progression beyond anteromedial osteoarthritis or a deficient anterior cruciate ligament, undergo TKA.

Participants are blinded to allocation. A standard-size sterile dressing is applied to the surgical wound by an independent healthcare support worker before biomechanical testing to conceal scar length, and participants are not shown their postoperative radiographs unless there is a clinical need. Research staff performing biomechanical assessment, outcome scoring, and statistical analysis are blinded to allocation, with unblinding only after analysis is complete. The treating surgeon cannot be blinded.

Assessments take place preoperatively, immediately postoperatively, and at six weeks, six months, and 12 months. Biomechanical assessment is performed in the centre's Motion Analysis Laboratory using a Vicon motion capture system (Vicon Motion Systems Ltd, Yarnton, UK) and two AMTI force plates (Advanced Mechanical Technology Inc., Watertown, Massachusetts, USA). Tasks are level walking, incline walking, decline walking, step ascent, step descent, sit-to-stand-to-sit, and single-leg balance.

A matched healthy control group is drawn from an existing motion analysis database held at the study centre, comprising individuals without known knee pathology previously assessed using an identical protocol under separate ethical approval. Control data do not contribute to the primary comparison between arms and are used only to contextualize findings against values expected in a healthy population. Healthy controls are not prospectively enrolled in this trial.

The sample size was calculated for the primary outcome, assuming 95 degrees for the UKA group and 89 degrees for the TKA group with a pooled standard deviation of 5.5 degrees, two-sided alpha of 0.05, and 80% power, giving 15 participants per group for an analysis of covariance with baseline as a covariate. Allowing for an estimated 10% intraoperative conversion from UKA to TKA and 15% loss to follow-up, the recruitment target is 20 per group. The trial is powered for the primary outcome alone, and all secondary outcomes are exploratory.

The primary analysis is performed on the per-protocol population, defined as participants who received their randomized implant and completed the 12-month biomechanical assessment. Participants found intraoperatively unsuitable for UKA at arthrotomy are excluded from the primary analysis regardless of allocation.

The trial is funded by Zimmer GmbH (Winterthur, Switzerland).

03

Conditions studied

  • Osteoarthritis
  • Knee
  • Arthroplasty
  • Replacement, Knee

Browse trials for

Keywords

  • Total knee arthroplasty
  • Partial knee arthroplasty
  • Unicondylar knee arthroplasty
  • Randomised controlled trial
  • Functional biomechanical assessment
  • Movement analysis
  • Gait analysis
  • Step descent
  • Knee kinematic
  • randomized controlled trial
04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Suitable for medial unicompartmental knee arthroplasty
  • Aged between 18 and 75 years inclusive
  • Taller than 1.5m in height (the 10th percentile for the population)
  • Functionally intact anterior cruciate ligament
  • Able to give
  • Able to return to the study centre for follow-up
  • under 40

Exclusion criteria

Exclusion Criteria:

  • Inflammatory joint disease e.g. rheumatoid arthritis
  • Previous hip procedure within the previous twelve months
  • Previous knee surgery other than arthroscopy and medial menisectomy
  • Previous ankle surgery
  • Symptomatic foot, hip or spinal pathology
  • Any medical condition limiting normal ambulation e.g. stroke, Charcot-Marie-Tooth disease, severe lymphedema, advanced cardiac disease
  • Unable to read and understand English and follow verbal and visual instructions unless they can bring a relative or friend to all study assessments to act as a translator
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Unicompartmental knee arthroplasty (UKA)

    Description: Cemented medial fixed-bearing unicompartmental knee arthroplasty, implanted using a spacer block technique that resurfaces the medial compartment without deliberate correction of limb alignment, using conventional manual instrumentation

    Device: Persona Partial Knee (PPK)

  • Active comparator
    Total knee arthroplasty (TKA)

    Cemented cruciate-retaining total knee arthroplasty without patellar resurfacing, implanted using a measured resection technique with a mechanical alignment target, using conventional manual instrumentation. This is the standard total knee implant used at the study centre.

    Device: Triathlon cruciate-retaining total knee system.

Interventions

  • DevicePersona Partial Knee (PPK)

    Cemented medial fixed-bearing unicompartmental knee arthroplasty using the Persona Partial Knee (PPK; Zimmer Biomet, Warsaw, Indiana, USA).

  • DeviceTriathlon cruciate-retaining total knee system.

    Cemented Triathlon cruciate-retaining total knee system without patellar resurfacing (Stryker, Mahwah, New Jersey, USA).

06

What researchers measure

Primary outcomes

  1. Maximum knee flexion of the operated knee during step descent

    Peak flexion angle of the operated knee in the sagittal plane, in degrees, during descent from a 20 cm step with the operated limb acting as the trailing limb, measured using three-dimensional motion analysis.

    Time frame: 12 months post-operatively

Secondary outcomes

  1. Maximum knee flexion during step descent, operated limb as trailing limb

    Time frame: 6 months post-operatively

  2. Knee kinematics and kinetics

    Knee kinematics: sagittal, coronal, and transverse plane joint angles during level walking, incline walking, decline walking, step ascent, step descent, and sit-to-stand-to-sit. Knee kinetics: knee joint moments and ground reaction forces during tasks performed on force plates.

    Time frame: baseline, 6 months, 12 months

  3. Spatiotemporal and balance

    Spatiotemporal gait parameters: walking speed and step length. Single-leg balance: time to failure, in seconds.

    Time frame: baseline, 6 months, 12 months.

  4. Patient satisfaction

    Patient satisfaction on a Fpur-point Likert scale.

    Time frame: 6 weeks, 6 months, 12 months

  5. Radiographic assessment

    11\. Radiographic assessment of implant position, alignment, and signs of loosening or migration, using a modified Knee Society Roentgenographic Evaluation and Scoring System. No summary score is produced.

    Time frame: to 12 months postoperatively

  6. Complications and adverse events

    12\. Complications and adverse events, including deep and superficial infection, thromboembolic events, intraoperative fracture, neurovascular injury, wound complications, and any reoperation or revision.

    Time frame: to 12 months postoperatively

  7. Implant survivorship

    Implant survivorship, reported as the number of implants in situ.

    Time frame: 12 months

  8. Intraoperative conversion from unicompartmental to total knee arthroplasty, reported as the number of participants.

    Time frame: day of surgery

Other outcomes

  1. Patient reported outcome (Oxford Knee Score)

    Oxford Knee Score, 12 items, total score 0 to 48, higher scores indicate better outcome.

    Time frame: baseline, 6 weeks, 6 months, 12 months.

  2. Patient reported outcome (EuroQual 5D-5L questionnaire)

    9\. EQ-5D-5L index value and visual analogue scale.

    Time frame: baseline, 6 weeks, 6 months, 12 months.

  3. Patient reported outcome (Forgotten Joint Score)

    Forgotten Joint Score-12, score 0 to 100, higher scores indicate greater ability to forget the operated joint.

    Time frame: 6 weeks, 6 months, 12 months.

  4. Patient reported outcome (University of California Los Angelees Activity Score)

    8\. UCLA Activity Score, single item, 1 to 10, higher scores indicate greater activity.

    Time frame: baseline, 6 weeks, 6 months, 12 months.

07

Study locations

1 site
08

References and documents

Publications

  • Kuntze G, Panjavi S, Henning E, Korley R, Abelseth G, Ronsky J, Johnston K. Preserving Patient-Specific Knee Motion: A Randomized Clinical Trial of Unicompartmental and Total Knee Arthroplasty. J Orthop Res. 2025 Dec;43(12):2203-2211. doi: 10.1002/jor.70077. Epub 2025 Oct 3. PubMed 41044992 ↗
  • Jung MC, Chung JY, Son KH, Wang H, Hwang J, Kim JJ, Kim JH, Min BH. Difference in knee rotation between total and unicompartmental knee arthroplasties during stair climbing. Knee Surg Sports Traumatol Arthrosc. 2014 Aug;22(8):1879-86. doi: 10.1007/s00167-014-3064-8. Epub 2014 May 24. PubMed 24859731 ↗
  • Bjerke J, Ohberg F, Nilsson KG, Foss OA, Stensdotter AK. Peak knee flexion angles during stair descent in TKA patients. J Arthroplasty. 2014 Apr;29(4):707-11. doi: 10.1016/j.arth.2013.07.010. Epub 2013 Aug 9. PubMed 23937925 ↗
  • Copp EH, Gale TH, Byrapogu VKC, Urish KL, Anderst WJ. Unicompartmental knee arthroplasty approximates healthy knee kinematics more closely than total knee arthroplasty. J Orthop Res. 2024 Nov;42(11):2514-2524. doi: 10.1002/jor.25926. Epub 2024 Jul 2. PubMed 38956422 ↗
  • Komnik I, David S, Funken J, Haberer C, Potthast W, Weiss S. Compromised knee internal rotation in total knee arthroplasty patients during stair climbing. PLoS One. 2018 Oct 10;13(10):e0205492. doi: 10.1371/journal.pone.0205492. eCollection 2018. PubMed 30304032 ↗
  • Komnik I, Peters M, Funken J, David S, Weiss S, Potthast W. Non-Sagittal Knee Joint Kinematics and Kinetics during Gait on Level and Sloped Grounds with Unicompartmental and Total Knee Arthroplasty Patients. PLoS One. 2016 Dec 21;11(12):e0168566. doi: 10.1371/journal.pone.0168566. eCollection 2016. PubMed 28002437 ↗
  • Dong M, Fan H, Yang D, Sun X, Yan C, Feng Y. Comparison of spatiotemporal, kinematic, and kinetic gait characteristics in total and unicompartmental knee arthroplasty during level walking: A systematic review and meta-analysis. Gait Posture. 2023 Jul;104:58-69. doi: 10.1016/j.gaitpost.2023.06.005. Epub 2023 Jun 7. PubMed 37321113 ↗
  • Bayram JM, Clement ND, Hall AJ, Walmsley P, Clarke JV. Are Current Patient-Reported Outcome Measures Fit for Purpose to Evaluate Unicompartmental Knee Arthroplasty? J Clin Med. 2025 Jan 2;14(1):203. doi: 10.3390/jcm14010203. PubMed 39797286 ↗
  • Eckhard L, Munir S, Wood D, Talbot S, Brighton R, Walter B, Bare J. The ceiling effects of patient reported outcome measures for total knee arthroplasty. Orthop Traumatol Surg Res. 2021 May;107(3):102758. doi: 10.1016/j.otsr.2020.102758. Epub 2020 Dec 11. PubMed 33316442 ↗
  • Mohammad HR, Liddle AD, Judge A, Murray DW. A Matched Comparison of Long-Term Outcomes of Total and Unicompartmental Knee Replacements in Different Ages Based on National Databases: Analysis of Data From the National Joint Registry for England, Wales, Northern Ireland, and the Isle of Man. J Arthroplasty. 2022 Feb;37(2):243-251. doi: 10.1016/j.arth.2021.09.018. Epub 2021 Oct 5. PubMed 34619307 ↗
  • Bin G, Jinmin L, Cong T, Yuchen T, Xiaohui Z, Yayi X. Surgical interventions for symptomatic knee osteoarthritis: a network meta-analysis of randomized control trials. BMC Musculoskelet Disord. 2023 Apr 22;24(1):313. doi: 10.1186/s12891-023-06403-z. PubMed 37087428 ↗
  • Beard DJ, Davies LJ, Cook JA, MacLennan G, Hudson J, Price AJ, Carr AJ, Little M, Leal J, Fitzpatrick R, Murray DW, Campbell MK; TOPKAT Study Group. Assessing clinical and cost effectiveness of total versus partial knee replacement (TOPKAT): 10-year follow-up of a multicentre, randomised controlled trial. Lancet Rheumatol. 2026 Feb;8(2):e116-e126. doi: 10.1016/S2665-9913(25)00250-4. Epub 2025 Nov 18. PubMed 41270774 ↗
  • Beard DJ, Davies LJ, Cook JA, MacLennan G, Price A, Kent S, Hudson J, Carr A, Leal J, Campbell H, Fitzpatrick R, Arden N, Murray D, Campbell MK; TOPKAT Study Group. The clinical and cost-effectiveness of total versus partial knee replacement in patients with medial compartment osteoarthritis (TOPKAT): 5-year outcomes of a randomised controlled trial. Lancet. 2019 Aug 31;394(10200):746-756. doi: 10.1016/S0140-6736(19)31281-4. Epub 2019 Jul 17. PubMed 31326135 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2021 (actual). Primary completion is estimated for Oct 2027, 77 months after the start.

Of 578 non-industry interventional studies with no phase under Osteoarthritis, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 51. This study's planned 77 months is above that.

Counting every sponsor, half of 713 studies reached it within 28 months; a quarter within 11 and three quarters within 57.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 17, 2019
First posted
Jun 4, 2021
StartActual
Apr 26, 2021
Primary completionEst.
Oct 15, 2027
CompletionEst.
Oct 15, 2027
Last update
Sep 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04913987
Lead sponsor
Golden Jubilee National Hospital
Responsible party
Sponsor
First posted
Jun 4, 2021
Start date
Apr 26, 2021
Primary completion
Oct 15, 2027 (estimated)
Completion
Oct 15, 2027 (estimated)
Last update
Sep 24, 2026

Study contacts

Nicholas Ohly, FRCS Ed
principal investigator · Golden Jubilee University National Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion